Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Plume
AddedFeb 17, 2024
UpdatedJun 18, 2026
Plume

Plume

Series B

Plume: A health tech company dedicated to serving the transgender community.

HQ
Denver, CO, US
Founded
2019
Overview
Compare
Fundraising
Employees
News
Website

Founded to address the unique healthcare needs of the transgender community, Plume is a health tech company that provides comprehensive, gender-affirming care. Their core mission is to create a virtual home where transgender, nonbinary, and gender non-conforming individuals can access specialized medical services. Plume offers a range of healthcare services, including hormone therapy, transition support, and medications for mental health conditions like anxiety and depression, all for a monthly subscription fee.

Plume has garnered attention for its innovative approach to healthcare, attracting notable investors and advisors from the health tech and LGBTQ+ advocacy sectors. The company’s key achievements include expanding access to gender-affirming care across multiple states and receiving positive testimonials from users who have found a supportive and understanding healthcare environment. Plume's impact is significant, providing an essential service that improves the quality of life for many in the transgender community.

Plume - Similar Companies

Folx Health logo

Folx Health

folxhealth.com

Paloma Health logo

Paloma Health

palomahealth.com

Bloomojo logo

Bloomojo

bloomojo.com

MyTransHealth logo

MyTransHealth

Alpha Medical logo

Alpha Medical

helloalpha.com

Transcarent logo

Transcarent

transcarent.com

Elektra Health logo

Elektra Health

elektrahealth.com

Spruce Health logo

Spruce Health

sprucehealth.com

Path logo

Path

pathccm.com

Amaze Health logo

Amaze Health

amazehealth.com

Euphoria.Lgbt logo

Euphoria.Lgbt

euphoria.lgbt

Troglo logo

Troglo

troglo.io

Kaden Health logo

Kaden Health

kadenhealth.com

Comet Health logo

Comet Health

trycomet.com

The Cusp logo

The Cusp

Plume - Quick Facts

Who are Plume's competitors?

Companies similar to Plume include Folx Health, Paloma Health, Bloomojo and MyTransHealth.

When was Plume founded?

Plume was founded in 2019.

Where is Plume's headquarters located?

Plume's headquarters is located in Denver, CO, US.

When was Plume's last funding round?

Plume's most recent funding round was for $24M (USD) in August 2022.

How much has Plume raised to-date?

As of Aug 23, 2022, Plume has raised a total of $38M (USD).

How many employees does Plume have?

Plume has 19 employees as of Feb 4, 2024.

Plume - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Healthcare
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software